SS Innovations International (NASDAQ: SSII) is positioning itself as a key player in the medical robotics space by prioritizing affordability and accessibility, according to a recent Medsider interview with founder, chairman and CEO Dr. Sudhir Srivastava. The company’s strategy centers on lowering the cost of robotic surgery through its SSi Mantra system, which supports multiple specialties including cardiac surgery, while expanding into global markets.
Dr. Srivastava emphasized that the company’s objective is not merely to compete with existing robotic surgery platforms but to broaden access for hospitals and patients historically unable to adopt the technology due to high equipment costs and operational expenses. The SSi Mantra system, designed to reduce costs, has already been installed in more than 200 locations, with over 11,700 robotic procedures completed, including more than 170 telesurgeries.
Artificial intelligence, automation, and new robotic platforms remain central to SS Innovations’ long-term product roadmap. Telesurgery and teleproctoring are becoming important differentiators, allowing expert surgeons to support complex procedures remotely, which could significantly expand the reach of specialized surgical care to underserved regions.
The company is pursuing regulatory approvals from the U.S. Food and Drug Administration (FDA) and European authorities while expanding into additional international markets. This regulatory push, combined with a growing installed base, positions SS Innovations to capture a share of the global surgical robotics market, which is expected to grow substantially in the coming years.
For investors evaluating emerging medical technology companies, the competitive advantages behind a product can be as important as financial results. Dr. Srivastava’s focus on cost reduction and remote capabilities underscores the company’s potential to disrupt the robotic surgery landscape, currently dominated by high-cost systems. The ability to perform telesurgeries could also open new revenue streams and partnerships with healthcare systems in remote areas.
Full terms of use and disclaimers are available on the InvestorBrandNetwork website. Forward-looking statements in this article involve risks and uncertainties, as detailed in the company’s filings with the SEC, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The original release is available on NewMediaWire.
